Novo Nordisk updates Wegovy labeling in Singapore with STEP UP clinical data as S&P 500 healthcare developments continue ...

A new NIH-funded study led by a MaineHealth researcher will examine early-life exposure to PFAS "forever chemicals" and ...

But at this stage of Eli Lilly's crucial obesity-drug business, the greenest pastures are currently overseas.

Although Viking Therapeutics VKTX isn’t officially on the auction block, investors are increasingly viewing it as a potential ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

The Green Revolution’s genius was carbohydrate abundance. Its unintended bequest is a carbohydrate-dependent plate. The 2023 ...

Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...

Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...

The Medicare GLP-1 Bridge will start July 1. Regardless of the balance sheet, the responsible choice, says Dr Amy Faith Ho, is not to wait until obesity becomes a heart attack, a dialysis chair, or ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Risk factors for cardiovascular disease have been formally identified for over six decades. Providing education and targeting ...